Back
Coherus Oncology, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
29
CHRS
Coherus Oncology, Inc.
Last Price:
$1.21
Seasonality Move:
0.05%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCoherus Oncology, Inc. Stock Forecast
-
Is Coherus Oncology, Inc. Stock Undervalued?The current Coherus Oncology, Inc. [CHRS] share price is $1.20. The Score for CHRS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
CHRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Coherus Oncology, Inc. Stock Go Up Next Year?
Data Unavailable
Coherus Oncology, Inc. Stock Rating
Data Unavailable
Coherus Oncology, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
coherus.com
52-Week Data
52-Week High:
1.89
52-Week Low:
0.71
Prediction Charts
Market Cap:
145M
Price in USD:
1.20
Volume:
1M
Beta:
1.42
Technical Analysis
SMA50:
1.50
SMA100:
1.32
SMA200:
1.11
52-Wk Change:
-20.53%
Stock Predictions
-
Is Coherus Oncology, Inc. stock public?Yes, Coherus Oncology, Inc. is a publicly traded company.
-
What is the Coherus Oncology, Inc. stock quote today?The Coherus Oncology, Inc. stock price is 1.20 USD today.
-
How to buy Coherus Oncology, Inc. stock online?You can buy Coherus Oncology, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 1.18 | 1.13 | 1.24 | 1.10 |
| Nov-18 | 1.10 | 1.21 | 1.25 | 1.10 |
| Nov-19 | 1.20 | 1.16 | 1.23 | 1.16 |
| Nov-20 | 1.18 | 1.10 | 1.22 | 1.09 |
| Nov-21 | 1.09 | 1.16 | 1.17 | 1.09 |
| Nov-24 | 1.15 | 1.28 | 1.30 | 1.15 |
| Nov-25 | 1.29 | 1.28 | 1.31 | 1.24 |
| Nov-26 | 1.27 | 1.31 | 1.32 | 1.25 |
| Nov-28 | 1.34 | 1.36 | 1.39 | 1.33 |
| Dec-1 | 1.31 | 1.27 | 1.33 | 1.26 |
| Dec-2 | 1.28 | 1.16 | 1.32 | 1.16 |
| Dec-3 | 1.18 | 1.22 | 1.25 | 1.15 |
| Dec-4 | 1.22 | 1.23 | 1.25 | 1.20 |
| Dec-5 | 1.25 | 1.20 | 1.27 | 1.18 |
Coherus Oncology, Inc. Earnings
Data Unavailable
Coherus Oncology, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and an increase next year of $0.84 per share.
* Coherus Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.